Spondyloepimetaphyseal dysplasia, Strudwick type
Spondyloepimetaphyseal Dysplasia, Strudwick Type (SEMD, Strudwick Type) is a rare genetic disorder that affects the development of bones, particularly those in the spine (vertebrae), the ends of long bones (epiphyses), and the bones of the chest. This condition is part of a group of diseases known as skeletal dysplasias, which are characterized by abnormalities in the size and shape of the limbs, trunk, and skull.
Symptoms and Characteristics[edit | edit source]
Patients with Spondyloepimetaphyseal Dysplasia, Strudwick Type, typically present with a short stature, a short and curved spine (scoliosis and/or kyphosis), and abnormalities in the shape of the pelvis, chest, and long bones. The condition is also associated with problems in the development of the epiphyseal plate, leading to shortening and deformities of the limbs. Other common features include a barrel-shaped chest, a protruding abdomen, and distinctive facial features such as a prominent forehead, a flat nasal bridge, and a small chin.
Genetics[edit | edit source]
Spondyloepimetaphyseal Dysplasia, Strudwick Type is inherited in an autosomal dominant manner, meaning that only one copy of the altered gene is necessary to cause the disorder. It is caused by mutations in the COL2A1 gene, which provides instructions for making a protein that is essential for the development and maintenance of the cartilage that forms the body's skeletal framework. Mutations in the COL2A1 gene disrupt the normal formation of collagen, leading to the skeletal abnormalities seen in this condition.
Diagnosis[edit | edit source]
Diagnosis of Spondyloepimetaphyseal Dysplasia, Strudwick Type is primarily based on the clinical presentation and radiographic findings. Genetic testing can confirm the diagnosis by identifying a mutation in the COL2A1 gene. Prenatal diagnosis is possible if there is a known family history of the condition.
Treatment[edit | edit source]
There is no cure for Spondyloepimetaphyseal Dysplasia, Strudwick Type, and treatment focuses on managing symptoms and improving quality of life. This may include physical therapy, orthopedic interventions such as surgery to correct bone deformities or to manage scoliosis, and other supportive treatments. Growth hormone therapy has been used in some cases to increase stature, although its effectiveness varies.
Prognosis[edit | edit source]
The prognosis for individuals with Spondyloepimetaphyseal Dysplasia, Strudwick Type varies. While some individuals may have mild symptoms and lead relatively normal lives, others may experience significant physical limitations. Early and ongoing management of the condition is important to address any complications that arise and to improve overall quality of life.
Spondyloepimetaphyseal dysplasia, Strudwick type Resources | ||
---|---|---|
|
|
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD